Annual report pursuant to Section 13 and 15(d)

Nature of Business and Significant Accounting Policies (Tables)

v3.21.1
Nature of Business and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Common Control and Ownership Interest

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2020:

 

    State of    
Name of Entity   Incorporation   Relationship
One World Pharma, Inc.(1)   Nevada   Parent
OWP Ventures, Inc.(2)   Delaware   Subsidiary
One World Pharma S.A.S.(3)   Colombia   Subsidiary
Colombian Hope, S.A.S.(4)   Colombia   Subsidiary